Eva Ehrnrooth
Profile
Eva Ehrnrooth worked as a Medical Director in Oncology at Novo Nordisk A from 2006 to 2008, and at Genmab A from 2008 to 2010.
She is currently the Chief Medical Officer at IO Biotech, Inc. since 2017.
Dr. Ehrnrooth holds a doctorate degree from the University of Aarhus.
Former positions of Eva Ehrnrooth
| Companies | Position | End |
|---|---|---|
| IO BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 18/07/2023 |
| GENMAB A/S | Chief Tech/Sci/R&D Officer | 01/02/2010 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/05/2008 |
Training of Eva Ehrnrooth
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Genmab A/S
Genmab A/S Pharmaceuticals: MajorHealth Technology Develops differentiated antibody therapeutics for treatment of cancer | Health Technology |
University of Aarhus
University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IO Biotech, Inc.
IO Biotech, Inc. Operates as a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies |
- Stock Market
- Insiders
- Eva Ehrnrooth
















